Global Antacid Suspensions Market Insights, Forecast to 2025
Table of Contents
1 Study Coverage
- 1.1 Antacid Suspensions Product Introduction
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Antacid Suspensions Market Size Growth Rate by Type
- 1.4.2 Aluminum Products
- 1.4.3 Magnesium Products
- 1.4.4 Calcium Products
- 1.5 Market by Application
- 1.5.1 Global Antacid Suspensions Market Size Growth Rate by Application
- 1.5.2 Hospitals
- 1.5.3 Clinics
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Antacid Suspensions Market Size
- 2.1.1 Global Antacid Suspensions Revenue 2014-2025
- 2.1.2 Global Antacid Suspensions Sales 2014-2025
- 2.2 Antacid Suspensions Growth Rate by Regions
- 2.2.1 Global Antacid Suspensions Sales by Regions
- 2.2.2 Global Antacid Suspensions Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Antacid Suspensions Sales by Manufacturers
- 3.1.1 Antacid Suspensions Sales by Manufacturers
- 3.1.2 Antacid Suspensions Sales Market Share by Manufacturers
- 3.2 Antacid Suspensions Revenue by Manufacturers
- 3.2.1 Antacid Suspensions Revenue by Manufacturers (2014-2019)
- 3.2.2 Antacid Suspensions Revenue Share by Manufacturers (2014-2019)
- 3.3 Antacid Suspensions Price by Manufacturers
- 3.4 Antacid Suspensions Manufacturing Base Distribution, Product Types
- 3.4.1 Antacid Suspensions Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Antacid Suspensions Product Type
- 3.4.3 Date of International Manufacturers Enter into Antacid Suspensions Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
- 4.1 Global Antacid Suspensions Sales by Type
- 4.2 Global Antacid Suspensions Revenue by Type
- 4.3 Antacid Suspensions Price by Type
5 Breakdown Data by Application
- 5.1 Overview
- 5.2 Global Antacid Suspensions Breakdown Data by Application
6 North America
- 6.1 North America Antacid Suspensions by Country
- 6.1.1 North America Antacid Suspensions Sales by Country
- 6.1.2 North America Antacid Suspensions Revenue by Country
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Antacid Suspensions by Type
- 6.3 North America Antacid Suspensions by Application
7 Europe
- 7.1 Europe Antacid Suspensions by Country
- 7.1.1 Europe Antacid Suspensions Sales by Country
- 7.1.2 Europe Antacid Suspensions Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Antacid Suspensions by Type
- 7.3 Europe Antacid Suspensions by Application
8 Asia Pacific
- 8.1 Asia Pacific Antacid Suspensions by Country
- 8.1.1 Asia Pacific Antacid Suspensions Sales by Country
- 8.1.2 Asia Pacific Antacid Suspensions Revenue by Country
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Antacid Suspensions by Type
- 8.3 Asia Pacific Antacid Suspensions by Application
9 Central & South America
- 9.1 Central & South America Antacid Suspensions by Country
- 9.1.1 Central & South America Antacid Suspensions Sales by Country
- 9.1.2 Central & South America Antacid Suspensions Revenue by Country
- 9.1.3 Brazil
- 9.1.4 Argentina
- 9.2 Central & South America Antacid Suspensions by Type
- 9.3 Central & South America Antacid Suspensions by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Antacid Suspensions by Country
- 10.1.1 Middle East and Africa Antacid Suspensions Sales by Country
- 10.1.2 Middle East and Africa Antacid Suspensions Revenue by Country
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Antacid Suspensions by Type
- 10.3 Middle East and Africa Antacid Suspensions by Application
11 Company Profiles
- 11.1 AstraZeneca
- 11.1.1 AstraZeneca Company Details
- 11.1.2 Company Business Overview
- 11.1.3 AstraZeneca Antacid Suspensions Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 AstraZeneca Antacid Suspensions Products Offered
- 11.1.5 AstraZeneca Recent Development
- 11.2 Takeda Pharmaceutical
- 11.2.1 Takeda Pharmaceutical Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Takeda Pharmaceutical Antacid Suspensions Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Takeda Pharmaceutical Antacid Suspensions Products Offered
- 11.2.5 Takeda Pharmaceutical Recent Development
- 11.3 Pfizer
- 11.3.1 Pfizer Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Pfizer Antacid Suspensions Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Pfizer Antacid Suspensions Products Offered
- 11.3.5 Pfizer Recent Development
- 11.4 Gaviscon (Reckitt Benckiser)
- 11.4.1 Gaviscon (Reckitt Benckiser) Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Gaviscon (Reckitt Benckiser) Antacid Suspensions Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Gaviscon (Reckitt Benckiser) Antacid Suspensions Products Offered
- 11.4.5 Gaviscon (Reckitt Benckiser) Recent Development
- 11.5 Bayer
- 11.5.1 Bayer Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Bayer Antacid Suspensions Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Bayer Antacid Suspensions Products Offered
- 11.5.5 Bayer Recent Development
- 11.6 Procter&Gamble
- 11.6.1 Procter&Gamble Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Procter&Gamble Antacid Suspensions Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Procter&Gamble Antacid Suspensions Products Offered
- 11.6.5 Procter&Gamble Recent Development
- 11.7 GlaxoSmithKline (GSK)
- 11.7.1 GlaxoSmithKline (GSK) Company Details
- 11.7.2 Company Business Overview
- 11.7.3 GlaxoSmithKline (GSK) Antacid Suspensions Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 GlaxoSmithKline (GSK) Antacid Suspensions Products Offered
- 11.7.5 GlaxoSmithKline (GSK) Recent Development
- 11.8 Johnson&Johnson
- 11.8.1 Johnson&Johnson Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Johnson&Johnson Antacid Suspensions Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Johnson&Johnson Antacid Suspensions Products Offered
- 11.8.5 Johnson&Johnson Recent Development
- 11.9 CONBA
- 11.9.1 CONBA Company Details
- 11.9.2 Company Business Overview
- 11.9.3 CONBA Antacid Suspensions Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 CONBA Antacid Suspensions Products Offered
- 11.9.5 CONBA Recent Development
- 11.10 SPI Pharma
- 11.10.1 SPI Pharma Company Details
- 11.10.2 Company Business Overview
- 11.10.3 SPI Pharma Antacid Suspensions Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 SPI Pharma Antacid Suspensions Products Offered
- 11.10.5 SPI Pharma Recent Development
- 11.11 Sanofi
- 11.12 Bausch Health
- 11.13 Fidson Healthcare
12 Future Forecast
- 12.1 Antacid Suspensions Market Forecast by Regions
- 12.1.1 Global Antacid Suspensions Sales Forecast by Regions 2019-2025
- 12.1.2 Global Antacid Suspensions Revenue Forecast by Regions 2019-2025
- 12.2 Antacid Suspensions Market Forecast by Type
- 12.2.1 Global Antacid Suspensions Sales Forecast by Type 2019-2025
- 12.2.2 Global Antacid Suspensions Revenue Forecast by Type 2019-2025
- 12.3 Antacid Suspensions Market Forecast by Application
- 12.4 North America Antacid Suspensions Forecast
- 12.5 Europe Antacid Suspensions Forecast
- 12.6 Asia Pacific Antacid Suspensions Forecast
- 12.7 Central & South America Antacid Suspensions Forecast
- 12.8 Middle East and Africa Antacid Suspensions Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Antacid Suspensions Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Antacids are the most commonly used product for treating heartburn discomfort. And because they start to work in seconds, they're also the fastest way to relieve your symptoms.
The global Antacid Suspensions market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Antacid Suspensions market based on company, product type, end user and key regions.
This report studies the global market size of Antacid Suspensions in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Antacid Suspensions in these regions.
This research report categorizes the global Antacid Suspensions market by top players/brands, region, type and end user. This report also studies the global Antacid Suspensions market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
AstraZeneca
Takeda Pharmaceutical
Pfizer
Gaviscon (Reckitt Benckiser)
Bayer
Procter&Gamble
GlaxoSmithKline (GSK)
Johnson&Johnson
CONBA
SPI Pharma
Sanofi
Bausch Health
Fidson Healthcare
Antacid Suspensions market size by Type
Aluminum Products
Magnesium Products
Calcium Products
Antacid Suspensions market size by Applications
Hospitals
Clinics
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Antacid Suspensions market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Antacid Suspensions market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Antacid Suspensions companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Antacid Suspensions submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Antacid Suspensions are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Antacid Suspensions market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.